Zhang Qinren, Meng Ning, Liu Yu, Zhao Haiyan, Zhao Zhengtao, Hao Dan, Li Ruiding, Han Kunchen, Li He, Ma Jinke, Yu Xiaohan, Qi Zhongquan, Li Quanyang
College of Light Industry and Food Engineering, Guangxi University, Nanning, China.
Medical College, Guangxi University, Nanning, China.
Front Nutr. 2023 Jan 16;9:1070223. doi: 10.3389/fnut.2022.1070223. eCollection 2022.
Recent evidence supports a role for the gut microbe-metabolites in longevity. However, the phenomenon of hypertension is more common in the longevity area and whether hypertension is associated with longevity remains unclear. Here, we hypothesize that the levels of gut microbiota, SCFAs, and urine metabolites were different between hypertension elderly and hypertension longevity.
We recruited 46 elderly volunteers from Donglan County, Guangxi, and 32 were selected and included in the experiment. The subjects with hypertension were divided into two groups according to age, Hypertension Elderly (HTE, aged 70.5 ± 8.59, = 19) and Hypertension Longevity (HTL, aged 100 ± 5.72, = 13). The gut microbiota, SCFAs, and urine metabolites were determined by three-generation 16S rRNA full-length sequencing, GC-MS, and H-NMR, respectively.
Compared with the HTL group, the HTE group had higher levels of hypertension-related genera and , while having lower levels of the SCFA-producing genera , , and . Based on LEFse analysis, , , , and were biomarkers that showed significant differences between the groups. In addition, the microbial pathways associated with and may promote hypertension, while may play a role in reversing the development of hypertension in long-lived elderly. Metabolomics revealed that HTL contained a lower concentration of fecal acetate and propionate than HTE, while it contained a higher concentration of serum acetate and urine acetate. Furthermore, their immune cells exhibited no significant changes in SCFAs receptors.
Although long-lived elderly have extremely high systolic blood pressure, their unique gut microbiota composition and efficient acetate absorption in the colon may offset the damages caused by hypertension and maintain healthy homeostasis.
最近的证据支持肠道微生物代谢产物在长寿中发挥作用。然而,高血压现象在长寿地区更为常见,高血压与长寿是否相关仍不清楚。在此,我们假设高血压老年人和长寿高血压患者的肠道微生物群、短链脂肪酸(SCFAs)和尿液代谢产物水平存在差异。
我们从广西东兰县招募了46名老年志愿者,其中32名被选中纳入实验。患有高血压的受试者根据年龄分为两组,高血压老年人(HTE,年龄70.5±8.59岁,n = 19)和长寿高血压患者(HTL,年龄100±5.72岁,n = 13)。分别通过三代16S rRNA全长测序、气相色谱-质谱联用(GC-MS)和氢核磁共振(H-NMR)测定肠道微生物群、SCFAs和尿液代谢产物。
与HTL组相比,HTE组中与高血压相关的菌属[菌属名称1]和[菌属名称2]水平较高,而产生SCFAs的菌属[菌属名称3]、[菌属名称4]和[菌属名称5]水平较低。基于线性判别分析效应大小(LEFse)分析,[菌属名称6]、[菌属名称7]、[菌属名称8]和[菌属名称9]是两组间显示出显著差异的生物标志物。此外,与[菌属名称10]和[菌属名称11]相关的微生物途径可能促进高血压,而[菌属名称12]可能在逆转长寿老年人高血压发展中发挥作用。代谢组学显示,HTL的粪便乙酸盐和丙酸盐浓度低于HTE,而血清乙酸盐和尿液乙酸盐浓度较高。此外,他们的免疫细胞在SCFAs受体方面没有显著变化。
尽管长寿老年人收缩压极高,但其独特的肠道微生物群组成和结肠中高效的乙酸盐吸收可能抵消高血压造成的损害并维持健康的内环境稳态。